IMITREX 4 mg/.5mL (Sumatriptan INJECTION) 4 mg/.5mL

IMITREX 4 mg/0.5mL is a sumatriptan injection used for migraine relief. This subcutaneous treatment is designed for quick absorption and may help alleviate severe headache symptoms.

Strength

4 mg/.5mL

Pack Size

2 SYRINGE in 1 PACKAGE (0173-0739-00) / .5 mL in 1 SYRINGE

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IMITREX 4 mg/0.5mL is commonly used for the acute treatment of migraines with or without aura in adults. Sumatriptan, the active ingredient, is a selective serotonin receptor agonist that may help reduce the severity and duration of migraine attacks. People often ask, 'What is IMITREX used for?' and the primary use is for migraine relief.

Side Effects

When administered subcutaneously, IMITREX 4 mg/0.5mL may provide rapid relief from migraine pain. Common effects include temporary relief from headache, nausea, and sensitivity to light or sound. Some users may experience a reduction in migraine symptoms within 10 to 15 minutes of administration.

Precautions & Warnings

IMITREX 4 mg/0.5mL should be used with caution in individuals with a history of heart disease, high blood pressure, or seizures. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication as directed to maintain its efficacy.

Avoid Interactions

IMITREX 4 mg/0.5mL may interact with certain medications, including other migraine treatments, antidepressants, and drugs that affect serotonin levels. It is advisable to consult a healthcare provider before using IMITREX if you are taking other medications or have underlying health conditions.

Frequently Asked Questions

IMITREX 4 mg/0.5mL is primarily used for the acute treatment of migraines in adults.

IMITREX 4 mg/0.5mL is administered subcutaneously via injection.

Common side effects may include injection site reactions, nausea, and dizziness.

IMITREX is specifically indicated for migraines and not typically used for cluster headaches.

Long-term use of IMITREX should be discussed with a healthcare provider to assess potential risks and benefits.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.